FAT10 level in human gastric cancer and its relation with mutant p53 level, lymph node metastasis and TNM staging

Table 4 Relation between FAT10-mRNA level and clinicopathological factors for gastric cancer

Clinicopathological factors	Samples (n)	Positive samples	Strap gray value (mean ± SD)	t-value	P
Age (yr)
< 50	19	10	0.583 ± 0.036	1.12	> 0.05
≥ 50	43	26	0.611 ± 0.026
Sex
Male	38	21	0.622 ± 0.013	1.36	> 0.05
Female	24	15	0.574 ± 0.024
Tumor size (cm)
< 5 cm	33	19	0.594 ± 0.022	0.65	> 0.05
≥ 5 cm	29	17	0.590 ± 0.018
Location
Tantrum	31	17	0.537 ± 0.019	1.54	> 0.05
Angle	5	3	0.672 ± 0.037
Body	14	9	0.594 ± 0.021
Fundus	4	4	0.611 ± 0.025
Cardia	8	3	0.529 ± 0.032
Progression degree
Early	11	8	0.623 ± 0.023	1.15	> 0.05
Advanced	51	28	0.597 ± 0.020
Differentiation degree
Well-middle	15	9	0.564 ± 0.031	1.39	> 0.05
Low-non	47	27	0.595 ± 0.019
Lymph node metastasis
Positive	39	27	0.656 ± 0.016	3.37	< 0.01
Negative	23	9	0.531 ± 0.026
Distant metastasis
Positive	15	12	0.623 ± 0.033	1.74	> 0.05
Negative	47	24	0.598 ± 0.017
TNM stage
I + II	21	8	0.667 ± 0.023	2.25	< 0.05
III + IV	41	28	0.558 ± 0.015